Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Impairment of T cells’ antiviral and anti-inflammation immunities dominates death from COVID-19

Luhao Zhang, Rong Li, Gang Song, Gregory D. Scholes, Zhen-Su She
doi: https://doi.org/10.1101/2021.04.26.21256093
Luhao Zhang
1Institute of Health System Engineering, College of Engineering, Peking University, Beijing, China, 100871
2Department of Chemistry, Princeton University, Princeton, NJ, 08540
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rong Li
1Institute of Health System Engineering, College of Engineering, Peking University, Beijing, China, 100871
3State Key Laboratory for Turbulence and Complex Systems, Peking University, Beijing, China, 100871
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gang Song
4Beijing Hospital, National Center of Gerontology; Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China, 100730
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gregory D. Scholes
2Department of Chemistry, Princeton University, Princeton, NJ, 08540
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: gscholes@princeton.edu she@pku.edu.cn
Zhen-Su She
1Institute of Health System Engineering, College of Engineering, Peking University, Beijing, China, 100871
3State Key Laboratory for Turbulence and Complex Systems, Peking University, Beijing, China, 100871
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: gscholes@princeton.edu she@pku.edu.cn
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Clarifying dominant factors determining the immune heterogeneity from non-survivors to survivors is crucial for developing therapeutics and vaccines against COVID-19. The main difficulty is quantitatively analyzing the multi-level clinical data, including viral dynamics, immune response, and tissue damages. Here, we adopt a top-down modelling approach to quantify key functional aspects and their dynamical interplay in the battle between the virus and the immune system, yielding an accurate description of real-time clinical data involving hundreds of patients for the first time. The quantification of antiviral responses demonstrates that, compared to antibodies, T cells play a more dominant role in virus clearance, especially for mild patients (96.5%). Moreover, the anti-inflammatory responses, namely the cytokine inhibition and tissue repair rates, also positively correlate with T cell number and are significantly suppressed in non-survivors. Simulations show that the lack of T cells leads to more significant inflammation, proposing an explanation for the monotonous increase of COVID-19 mortality with age and higher mortality for males. We conclude that T cells play a crucial role in the immunity against COVID-19, which reveals a new direction——improvement of T cell number for advancing current prevention and treatment.

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

We used published data for study. We do not perform our own clinical trial

Funding Statement

The research is funded by the W.M. Keck Foundation through award no. 1005586. The authors acknowledge Prof. Kelvin To for sharing data, and Xiaoquan Wang, Guanghui She for discussion.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This is a theoretical work anaylizing clincal data that published previously so the ethical didelines are followed.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Competing Interest Statement: The authors declare no competing interests

  • According to reviewers' comments, we add further improvement with justifications of our theoretical arguments and more discussions of model verifications and results.

Data Availability

All the codes to produce figures in our manuscript can be accessed using the following link

https://github.com/luhaozhang/covid19.git

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted August 12, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Impairment of T cells’ antiviral and anti-inflammation immunities dominates death from COVID-19
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Impairment of T cells’ antiviral and anti-inflammation immunities dominates death from COVID-19
Luhao Zhang, Rong Li, Gang Song, Gregory D. Scholes, Zhen-Su She
medRxiv 2021.04.26.21256093; doi: https://doi.org/10.1101/2021.04.26.21256093
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Impairment of T cells’ antiviral and anti-inflammation immunities dominates death from COVID-19
Luhao Zhang, Rong Li, Gang Song, Gregory D. Scholes, Zhen-Su She
medRxiv 2021.04.26.21256093; doi: https://doi.org/10.1101/2021.04.26.21256093

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (227)
  • Allergy and Immunology (502)
  • Anesthesia (110)
  • Cardiovascular Medicine (1234)
  • Dentistry and Oral Medicine (206)
  • Dermatology (147)
  • Emergency Medicine (282)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (530)
  • Epidemiology (10015)
  • Forensic Medicine (5)
  • Gastroenterology (499)
  • Genetic and Genomic Medicine (2448)
  • Geriatric Medicine (236)
  • Health Economics (479)
  • Health Informatics (1638)
  • Health Policy (751)
  • Health Systems and Quality Improvement (636)
  • Hematology (248)
  • HIV/AIDS (532)
  • Infectious Diseases (except HIV/AIDS) (11862)
  • Intensive Care and Critical Care Medicine (625)
  • Medical Education (252)
  • Medical Ethics (74)
  • Nephrology (268)
  • Neurology (2278)
  • Nursing (139)
  • Nutrition (350)
  • Obstetrics and Gynecology (453)
  • Occupational and Environmental Health (534)
  • Oncology (1245)
  • Ophthalmology (375)
  • Orthopedics (133)
  • Otolaryngology (226)
  • Pain Medicine (155)
  • Palliative Medicine (50)
  • Pathology (324)
  • Pediatrics (729)
  • Pharmacology and Therapeutics (311)
  • Primary Care Research (282)
  • Psychiatry and Clinical Psychology (2280)
  • Public and Global Health (4829)
  • Radiology and Imaging (834)
  • Rehabilitation Medicine and Physical Therapy (490)
  • Respiratory Medicine (651)
  • Rheumatology (283)
  • Sexual and Reproductive Health (237)
  • Sports Medicine (226)
  • Surgery (266)
  • Toxicology (44)
  • Transplantation (125)
  • Urology (99)